Invention Grant
- Patent Title: Arylpyrrolopyridine derived compounds as LRRK2 inhibitors
-
Application No.: US15288255Application Date: 2016-10-07
-
Publication No.: US09675594B2Publication Date: 2017-06-13
- Inventor: Simon Timothy Bedford , I-Jen Chen , Yikang Wang , Douglas Stewart Williamson
- Applicant: H. Lundbeck A/S , Vernalis (R&D) Ltd.
- Applicant Address: DK Valby
- Assignee: H. Lundbeck A/S
- Current Assignee: H. Lundbeck A/S
- Current Assignee Address: DK Valby
- Agency: AuerbachSchrot LLC
- Agent Jeffrey I. Auerbach
- Priority: DK201300231 20130418
- Main IPC: C07D401/02
- IPC: C07D401/02 ; C07D401/14 ; A61K31/437 ; A61K31/4353 ; C07D471/04 ; A61K31/444 ; A61K31/5377
Abstract:
The present invention is directed to arylpyrrolopyridine derivatives of Formula A: The compounds are considered useful for the treatment of diseases associated with LRRK2 such as Lewy body dementia, Parkinson's disease or cancer.
Public/Granted literature
- US20170020850A1 Arylpyrrolopyridine Derived Compounds as LRRK2 Inhibitors Public/Granted day:2017-01-26
Information query
